CITIUS ONCOLOGY, INC. (CTOR) Executive Compensation
CITIUS ONCOLOGY, INC. (CTOR) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CTOR
CIK: 1851484
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 09/30
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Wolf & Company, P.C.
Auditor SinceSince 9/30/2024 12:00:00 AM
Lead Engagement PartnerDerek Thomas
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-29 | 2026-09-29 | CURRENT REPORT | 0001213900-26-104694 | View SEC Doc Filr Page |
| ARS | 2026-08-26 | 2025-09-30 | FORM ARS | 0001213900-26-093758 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-26 | 2026-09-29 | DEFINITIVE PROXY STATEMENT | 0001213900-26-093757 | View SEC Doc Filr Page |
| 3 | 2026-08-14 | 2026-08-10 | PRIMARY DOCUMENT | 0002149660-26-000001 | View SEC Doc Filr Page |
| 424B3 | 2026-08-14 | — | PROSPECTUS | 0001213900-26-090293 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-090184 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | CURRENT REPORT | 0001213900-26-090182 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003568 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-07 | CURRENT REPORT | 0001213900-26-088068 | View SEC Doc Filr Page |
| 424B3 | 2026-08-05 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-085679 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | CURRENT REPORT | 0001213900-26-085434 | View SEC Doc Filr Page |
| EFFECT | 2026-06-05 | — | EFFECT Filing | 9999999995-26-001912 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-04 | — | SCHEDULE 13D/A Filing | 0001213900-26-065310 | View SEC Doc Filr Page |
| CORRESP | 2026-06-03 | — | CORRESP Filing | 0001213900-26-064738 | View SEC Doc Filr Page |
| UPLOAD | 2026-06-03 | — | UPLOAD Filing | 0000000000-26-005598 | View SEC Doc Filr Page |
| 424B3 | 2026-06-01 | — | 424B3 | 0001213900-26-063546 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-06-01 | CURRENT REPORT | 0001213900-26-063530 | View SEC Doc Filr Page |
| DEF 14C | 2026-05-29 | 2026-05-29 | DEFINITIVE INFORMATION STATEMENT | 0001213900-26-062911 | View SEC Doc Filr Page |
| S-3 | 2026-05-29 | — | REGISTRATION STATEMENT | 0001213900-26-062864 | View SEC Doc Filr Page |
| 424B3 | 2026-05-22 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-060571 | View SEC Doc Filr Page |
| PRE 14C | 2026-05-19 | 2026-05-19 | PRELIMINARY INFORMATION STATEMENT | 0001213900-26-059053 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | CURRENT REPORT | 0001213900-26-057883 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-057841 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001172661-26-002138 | View SEC Doc Filr Page |
| 424B3 | 2026-05-06 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-052840 | View SEC Doc Filr Page |